Neopterin levels in patients with coronary artery disease are independent of Chlamydia pneumoniae seropositivity

American Heart Journal

Volumn 146, Issue 1, 2003, Pages 69-74

  Smith, David A ^a   Zouridakis, Emmanouil G ^a   Mariani, Matteo ^a   Fredericks, Salim ^a   Cole, Della ^a   Kaski, Juan Carlos ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEOPTERIN;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BIOAVAILABILITY; CHLAMYDOPHILA PNEUMONIAE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOASSAY; MACROPHAGE ACTIVATION; MALE; MEDICAL ASSESSMENT; MICROIMMUNOFLUORESCENCE ASSAY; PRIORITY JOURNAL; PROBABILITY;

EID: 0037485567     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00101-7     Document Type: Article

References (32)

1. Ross R. Atheroslerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
2. Koenig W, Sund M, Fröhlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Circulation 1999;99:237-42.
3. Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994;90:775-8.
4. Van der Wal AC, Becker AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterised by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
5. Libby P. Molecular basis of the acute coronary syndromes. Circulation 1995;91:2844-50.
6. Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin: release from macrophages primarily under control of interferon-gamma. J Exp Med 1984;160:310-6.
7. Gupta S, Fredericks S, Schwartzman RA, et al. Serum neapterin in acute coronary syndromes. Lancet 1997;349:1252 [letter].
8. Schumacher M, Halwachs G, Tatzber F, et al. Increased neapterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol 1997;30:703-7.
9. Garcia-Moll X, Cole D, Zouridakis E, et al. Increased serum neopterin: a marker of coronary artery disease activity in women. Heart 2000;83:346-50.
10. Garcia-Moll X, Coccolo F, Cole D, et al. Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol 2000;35:956-62.
11. Kaski JC, Chester MR, Chen L, et al. Rapid angiographic progression of coronary artery disease in patients with angina pectoris: the role of complex stenosis morphology. Circulation 1995;92:2058-65.
12. Chen L, Chester MR, Redwood S, et al. Angiographic stenosis progression and coronary events in patients with "stabilised" unstable angina. Circulation 1995;91:2319-24.
13. Ambrose J. Prognostic implications of lesion irregularity on coronary angiography. J Am Coll Cardiol 1991;18:675-6.
14. Caligiuri G, Liuzzo G, Biasucci LM, et al. Immune system activation follows inflammation in unstable angina: pathogenetic implications. J Am Coll Cardiol 1998;32:1295-304.
15. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
16. Wong Y-K, Gallagher PJ, Ward ME. Chlamydia pneumoniae and atherosclerosis. Heart 1999;81:232-8.
17. Ramirez JA. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae Atherosclerosis Study Group. Ann Int Med 1996;125:979-82.
18. Maass M, Bartels C, Engel PM, et al. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998;31:827-32.
19. Braunwald E. Unstable angina: a classification. Circulation 1989;80:410-4.
20. Gupta S, Leatham EW, Carrington D, et al. Elevated Chlamydia antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 1997;96:404-7.
21. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995;311:711-4.
22. Choussat R, Montalescot G, Collet J-P, et al. Effect of prior exposure to chlamydia pneumoniae, helicobacter pylori, or cytomegalovirus on the degree of inflammation and one year prognosis of patients with unstable angina pectoris or non-Q wave myocardial infarction. Am J Cardiol 2000;86:379-84.
23. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and the need for future research. Circulation 1997;96:4095-103.
24. Ridker PM, Kundsin RB, Stampfer PJ, et al. Prospective study of chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 1999;99:1161-4.
25. Hoffmeister A, Rothenbacher D, Wanner P, et al. Seropositivity to chlamydial lipopolysaccharide and chlamydia pneumoniae, systemic inflammation and stable coronary artery disease. J Am Coll Cardiol 2000;35:112-8.
26. Blasi F, Cosentini R. Laboratory diagnosis. In: Allegra L, Blasi F, editors. Chlamydia pneumoniae Infection. Milan: Springer-Verlag; 1995. p. 10-4.
27. Maass M, Krause E, Engel PM, et al. Endovascular presence of Chlamydia pneumoniae in patients with haemodynamically effective carotid stenosis. Angiology 1997;48:699-706.
28. Chiu B, Viira E, Tucker W, et al. Chlamydia peumoniae, cytomegaolvirus and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 1997;96:2144-8.
29. Wong Y, Dawkins KD, Ward ME. Circulating chlamydia pneumoniae DNA as a predictor of coronary artery disease. J Am Coll Cardiol 1999;34:1435-9.
30. Kaski JC, Camm AJ. Chlamydia pneumoniae infection and coronary artery disease. J Am Coll Cardiol 1999;34:1440-2.
31. Kaski JC. Increased neopterin in patients with chronic and acute coronary syndromes [letter]. J Am Coll Cardiol 1998;31:1215-6.
32. Ridker P, Cushman M, Stampfer M, et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Eng J Med 1997;336:973-9.